News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Mycotopia Therapies Announces Plan to Develop Psychedelic Sublingual Tablet to Help Treat Depression
Havn Life
MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures
Mind Medicine (MindMed)
Lobe Sciences Sponsors the International Summit on Psychedelic Therapies for Mental Illness
Lobe Sciences
Ketamine One Subsidiary IRP Health Opens Two New Veteran-Focused Clinics
Wellbeing Digital Sciences
Mydecine Reports Third Quarter 2021 Financial Results and Provides Business Update
Mydecine Innovations Group
Origin Therapeutics Announces Leadership Team
Origin Therapeutics
atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update
ATAI Life Sciences
Filament Health Reports Third Quarter 2021 Financial Results and Operational Highlights
Filament Health
Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory
Red Light Holland
MindMed Announces Financial Results for the Third Quarter 2021 and Business Highlights; Cash Balance of $145.9 USD ($185.4 CAD) to Execute on Diverse Clinical Pipeline
Mind Medicine (MindMed)
MindMed to Present at the Jefferies London Healthcare Conference
Mind Medicine (MindMed)
Daniel Cohen | CEO, Pharmadrug
Pharmadrug Inc.
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.